Long-term use of inhaled corticosteroids in chronic obstructive pulmonary disease patients is associated with significantly higher risks of type 2 diabetes, pneumonia, cataracts, osteoporosis, and nontraumatic fractures, as demonstrated by a large study. These findings highlight the need for reevaluation and cautious use of inhaled corticosteroids in COPD management to mitigate unnecessary risks and ensure patient safety.

Source: Annals of Family Medicine